Literature DB >> 11588116

Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy.

M R MacLean1, I Morecroft.   

Abstract

1. 5-Hydroxytryptamine (5-HT)(1)-receptor-induced contraction is enhanced, or uncovered, by elevated vascular tone in many arteries including pulmonary arteries. In hypoxia-induced pulmonary hypertension, the endogenous tone of pulmonary arteries is elevated and this may contribute to increased 5-HT(1)-receptor-induced contraction. Here we investigate the influence of vascular tone induced by endothelin-1 (ET-1), neuropeptide Y (NPY), KCl, 4-aminopyridine (inactivator of K(v) channels, 4-AP) or the calcium ionophore A23187 on contractile responses to the 5-HT(1)-receptor agonist 5-carboxamidotryptamine (5-CT) in small muscular pulmonary arteries from control rats and rats exposed to chronic hypoxia. The influence of the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME, 100 microM) was also studied. These conditions were chosen to mimic those that influence pulmonary vascular tone in hypoxia-induced pulmonary hypertension. 2. In control rat small pulmonary arteries, only high concentrations of 5-CT (>1 microM) induced vasoconstriction. Tone induced by NPY, 4-AP and A23187 had no effect on responses to 5-CT whilst responses to 5-CT were increased by ET-1- and KCl-induced tone. In the presence of L-NAME these responses to 5-CT were enhanced further. 3. Responses to 5-CT were enhanced 3 - 4 fold in small pulmonary arteries from hypoxia-exposed, pulmonary hypertensive rats and neither L-NAME nor increasing tone with NPY, 4-AP, A23187, ET-1 or KCl had any further effect on responses to 5-CT. 4. The results suggest that inhibition of nitric oxide synthase combined with KCl- or ET-1-induced vascular tone potentiates responses to 5-HT(1)-receptor-induced contraction in pulmonary arteries in a synergistic fashion and this mimics the effects of chronic hypoxic exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588116      PMCID: PMC1572973          DOI: 10.1038/sj.bjp.0704273

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension?

Authors:  M R MacLean
Journal:  J Lab Clin Med       Date:  1999-08

2.  Evidence for a 5-HT(1)-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery.

Authors:  I S de la Lande
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

3.  5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone.

Authors:  M R MacLean; R A Clayton; S W Hillis; P D McIntyre; A J Peacock; A G Templeton
Journal:  Pulm Pharmacol       Date:  1994-02

4.  Pharmacological characterization of the "silent" 5-hydroxytryptamine1B-like receptors of rabbit ear artery.

Authors:  H Movahedi; R E Purdy
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

Review 5.  Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?

Authors:  M R MacLean
Journal:  Trends Pharmacol Sci       Date:  1999-12       Impact factor: 14.819

6.  5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.

Authors:  I Morecroft; R P Heeley; H M Prentice; A Kirk; M R MacLean
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  A comparison of pathophysiological changes during hypobaric and normobaric hypoxia in rats.

Authors:  W Sheedy; J S Thompson; A H Morice
Journal:  Respiration       Date:  1996       Impact factor: 3.580

Review 8.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

9.  Inositol trisphosphate is involved in norepinephrine- but not in hypoxia-induced pulmonary arterial contraction.

Authors:  N Jin; C S Packer; D English; R A Rhoades
Journal:  Am J Physiol       Date:  1993-02

10.  Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells.

Authors:  T J Resink; T Scott-Burden; F R Bühler
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

View more
  13 in total

1.  Unoprostone activation of BK (KCa1.1) channel splice variants.

Authors:  Ling Yu; Amity F Eaton; Qiang Yue; Hui-Fang Bao; He-Ping Ma; John Cuppoletti; Douglas C Eaton
Journal:  Biochim Biophys Acta       Date:  2015-08-13

2.  Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension.

Authors:  Xiao-Ru Yang; Amanda H Y Lin; Jennifer M Hughes; Nicholas A Flavahan; Yuan-Ning Cao; Wolfgang Liedtke; James S K Sham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-29       Impact factor: 5.464

3.  Long-term maternal hypoxia: the role of extracellular Ca2+ entry during serotonin-mediated contractility in fetal ovine pulmonary arteries.

Authors:  Ravi Goyal; Demosthenes G Papamatheakis; Matthew Loftin; Kurt Vrancken; Antoinette S Dawson; Noah J Osman; Arlin B Blood; William J Pearce; Lawrence D Longo; Sean M Wilson
Journal:  Reprod Sci       Date:  2011-10       Impact factor: 3.060

4.  5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.

Authors:  R Murdoch; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

5.  NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.

Authors:  S Crnkovic; B Egemnazarov; P Jain; U Seay; N Gattinger; L M Marsh; Z Bálint; G Kovacs; B Ghanim; W Klepetko; R T Schermuly; N Weissmann; A Olschewski; G Kwapiszewska
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

6.  TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.

Authors:  Yang Xia; Zhenzhen Fu; Jinxing Hu; Chun Huang; Omkar Paudel; Shaoxi Cai; Wolfgang Liedtke; James S K Sham
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-05       Impact factor: 4.249

7.  A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.

Authors:  Emma Wallace; Nicholas W Morrell; Xudong D Yang; Lu Long; Hannah Stevens; Margaret Nilsen; Lynn Loughlin; Kirsty M Mair; Andrew H Baker; Margaret R MacLean
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

8.  Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension.

Authors:  Katie Y Hood; Kirsty M Mair; Adam P Harvey; Augusto C Montezano; Rhian M Touyz; Margaret R MacLean
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

9.  Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.

Authors:  Vladimir A Snetkov; Gavin D Thomas; Bonnie Teague; Richard M Leach; Yasin Shaifta; Greg A Knock; Philip I Aaronson; Jeremy P T Ward
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

10.  Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery.

Authors:  Nazinigouba Ouédraogo; Boutchi Mounkaïla; Huguette Crevel; Roger Marthan; Etienne Roux
Journal:  BMC Anesthesiol       Date:  2006-03-03       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.